Ga wasu daga cikin tambayoyin da aka fi tambaya game da Cutar Sikila na Yammacin Afirka. Za mu kara
ƙarin tambayoyi yayin da muke karɓa.
01 Ta yaya zan nemi taimako daga tushe?
Mafi yawan marasa lafiya an gano da mu tushe scouts (asibitin ma'aikata) a lokacin da suka yi su na yau da kullum al'umma dangantaka yawon shakatawa. Amma galibi muna samun kira daga iyaye / dangi na majiyyatan rashin lafiya, kuma a ƙa'ida, ba ma juyawa kowane mara lafiya baya, musamman jarirai da yara ƙanana. Don haka, hanya mafi kyau don tuntuɓar mu ita ce kiran lambobin asibitin mu na gida (wanda za'a buga nan ba da jimawa ba) ko tuntuɓi ofishin kamfanin mu a Columbus, Ohio, Amurka Lambar ita ce (614) 601-6505.
02 A matsayina na mara lafiya, shin ina bukatar in biya domin amfani da asibitin ku?
No. Duk sabis ana ba da su kyauta. Duk da haka, muna roƙon marasa lafiyar da za su iya ko waɗanda suke da dangi da za su iya ba da gudummawa, da su ba da gudummawa ga Gidauniyar Sickle Cell ta Afirka ta Yamma, don haka za mu ci gaba da taimaka wa waɗanda suke buƙatar taimako.
03 Ta yaya zan ba da gudummawa ga Gidauniyar Sickle Cell ta Afirka ta Yamma?
A kan wannan rukunin yanar gizon (ta hanyar latsa maballin "Gudummawa / Tallafawa"), ko kuna iya aika kuɗi ta hanyar Western Union da Money gram (Da fatan za a yi mana imel da lambar tabbatarwa), ko kuma kawai a aika da kuɗin kuɗinku ( Checks of Traveller , Bank Check, Binciken mai karbar kudi, Takardar Kudi, da katunan Kyautar da aka biya) zuwa:
Gidauniyar sikila ta Afirka ta Yamma
2021 E. Dublin Granville Road
Suite 276
Columbus, OH 43229
Codka jamhuuriyadda soomaaliya
04 Idan maras lafiya maraya ne fa?
Marayu ƙaunatattu ne ga zukatanmu, kuma za mu yi duk abin da zai yiwu don tabbatar da cewa sun sami mafi kyawun taimako da ake da shi. Idan za ta yiwu, za mu iya ajiye su a asibitin mu har sai gwamnati ta gano su dangin da za su yarda da su ..
05 Has the current worldwide pandemic affected your operations?
Not at all. If anything else, it has made us more resilient. We are fully persuaded that nothing will hinder us from fulfilling our calling and obligations to eradicate (or at least control) sickle cell in West Africa, and to give current sufferers a path to a normal life.